FGF10 and Alzheimer disease: Notably, intranasal administration of FGF10 and tail vein delivery of AAV‐mFGF10 effectively downregulated the expression of Aβ1‐40 and Aβ1‐42 in the cortex and hippocampus of 3xTg‐AD mice (Figure S5a–f,k–p).